Inpharmatis
↗Riga, Latvia
Inpharmatis is a premier pharmaceutical consulting firm and Contract Research Organization (CRO) headquartered in Riga, Latvia. Founded in 2006, the company provides comprehensive product lifecycle management services tailored for the pharmaceutical, biotechnology, medical device, and cosmetic industries. Their core service portfolio includes regulatory affairs, pharmacovigilance, GxP auditing (GMP/GDP), and market access strategy.
The company is recognized as a leading provider in the Baltic and CIS (Commonwealth of Independent States) markets, offering unique expertise in navigating the complex regulatory landscapes of these regions. Inpharmatis also features a dedicated eSolutions department that assists pharmaceutical companies in digitalizing their operations, specifically focusing on electronic Common Technical Document (eCTD) submissions and regulatory information management.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Regulatory Affairs and Pharmacovigilance Consulting
SIZE & FINANCIALS
Employees:1-50
Revenue:$350K-$500K
Founded:2006
Ownership:private
Status:operating
FUNDING
Stage:Self-funded/Private
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Biologics, Vaccines, Medical Devices
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Inpharmatis Group
Subsidiaries:Inpharmatis Ukraine, Inpharmatis Russia, Inpharmatis Uzbekistan
Key Partnerships:Extedo GmbH (Strategic partner for eCTD and regulatory software solutions), Various CIS regional regulatory bodies
COMPETITION
Position:Leader in Baltic/CIS Regulatory Consulting
Competitors:Abbott (Consulting arm), WuXi AppTec, Precision Medicine Group, Parexel, IQVIA
LEADERSHIP
Key Executives:
Tatjana Heimane - Digital Marketing Manager
Dr. Lucio van Rooijen - Former General Manager
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Inpharmatis. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.